These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11317875)
21. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751 [TBL] [Abstract][Full Text] [Related]
22. Chronic hepatitis and cirrhosis on MR imaging. Tonan T; Fujimoto K; Qayyum A Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):383-402, ix. PubMed ID: 21094446 [TBL] [Abstract][Full Text] [Related]
23. A young woman with cirrhosis: autoimmune hepatitis vs. alpha 1-antitrypsin deficiency. Lok AS; Ghany MG; Gerber MA Hepatology; 1994 May; 19(5):1302-6. PubMed ID: 8175155 [No Abstract] [Full Text] [Related]
25. Liver biopsy performance and histological findings among patients with chronic viral hepatitis: a Danish database study. Christensen PB; Krarup HB; Møller A; Laursen AL; Kjaer MS; Orholm M; Lindberg J; Groenbaek K; Kromann-Andersen H; Weis N; Scand J Infect Dis; 2007; 39(3):245-9. PubMed ID: 17366055 [TBL] [Abstract][Full Text] [Related]
26. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917 [TBL] [Abstract][Full Text] [Related]
27. Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis. Saleh HA; Abu-Rashed AH J Gastrointestin Liver Dis; 2007 Dec; 16(4):425-6. PubMed ID: 18193125 [No Abstract] [Full Text] [Related]
28. Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Berg T; Sarrazin C; Hinrichsen H; Buggisch P; Gerlach T; Zachoval R; Zeuzem S Hepatology; 2004 May; 39(5):1456-7; author reply 1457-8. PubMed ID: 15122779 [No Abstract] [Full Text] [Related]
29. [Diagnosis of chronic hepatitis]. Kuhn R; Rambach W; Kalk JF; Klein CP Dtsch Med Wochenschr; 1998 Sep; 123(36):1056-7. PubMed ID: 9765611 [No Abstract] [Full Text] [Related]
30. Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C. Svirtlih N; Jevtovic D; Simonovic J; Delic D; Dokic L; Gvozdenovic E; Boricic I; Nesic Z; Neskovic G; Urban V Hepatogastroenterology; 2007 Dec; 54(80):2324-7. PubMed ID: 18265657 [TBL] [Abstract][Full Text] [Related]
31. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449 [TBL] [Abstract][Full Text] [Related]
32. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410 [TBL] [Abstract][Full Text] [Related]
33. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis. Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034 [No Abstract] [Full Text] [Related]
34. Correlation of steatosis with fibrosis and necro-inflammation in chronic hepatitis C infection in the absence of confounding factors. Zubair A; Mubarik A; Jamal S; Arif A; Khan DA J Coll Physicians Surg Pak; 2009 Jul; 19(7):417-20. PubMed ID: 19576148 [TBL] [Abstract][Full Text] [Related]